Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001326110-23-000115

Chief Financial Officer acquired 70,744 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Sachs David C. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-01 Exercise or conversion : show line 1 in the form +70,744 122,042 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-01 Exercise or conversion : show line 2 in the form Restricted Stock Units −70,744 70,745 D
Loading xslF345X05/wk-form4_1694043655.xml…